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Edited by Hans-Dieter KlenkAbstract Members of the low-density lipoprotein receptor fam-
ily possess various numbers of ligand binding repeats that non-
equally contribute to binding of minor group human rhinoviruses.
Using an artiﬁcial concatemer of ﬁve copies of repeat 3 of the
human very-low density lipoprotein receptor, we demonstrate
protection of HRV2 against low-pH mediated uncoating and
inhibition of penetration of an RNA-speciﬁc ﬂuorescent dye into
the intact virion. This indicates that the recombinant receptor
inhibits viral breathing and irreversible conformational modiﬁ-
cations of the capsid that precede RNA release, providing a
new mechanism for rhinovirus neutralization by soluble receptor
molecules.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Human rhinoviruses (HRVs) are a major cause of the
common cold [1]. The 99 serotypes, two subgenera within the
picornavirus family, are positive sense single strand RNA-
containing icosahedral particles with roughly 30 nm diameter
[2]. They are built from 60 copies of each of the 4 capsid pro-
teins VP1–VP4 [3]. Twelve genus A HRVs, the minor group,
bind members of the low-density lipoprotein receptor (LDLR)
family, the remainder (the major group, including members of
genus A and B) bind intercellular adhesion molecule 1 (ICAM-
1) for cell entry. Despite extensive similarity of the sequences of
the capsid proteins and of the three-dimensional structures of
the serotypes the site and geometry of receptor attachment dif-
fers between the major and minor group. ICAM-1 binds within
the canyon, a cleft encircling the ﬁvefold axes of icosahedral
symmetry [4], whereas LDL-receptors rather attach to the
BC, DE, and HI loops of the viral capsid protein VP1 [5–7].
These loops are strongly exposed and make up a star-like dome
or plateau at the vertices of the icosahedron.
The picornaviral capsid is highly ﬂexible as seen from the
temporal exposure of parts of the innermost capsid protein*Corresponding author. Fax: +43 1 4277 9616.
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ing’’ is inhibited by antiviral agents [11], which bind into a
hydrophobic pocket below the canyon ﬂoor, where a fatty
acid-like molecule (pocket factor) is present in some HRV ser-
otypes [7]. This was shown by trypsin cleavage of sites seen to
be internal in the X-ray structure; in the presence of such drugs
a much lower amount of protein fragments is liberated. Fur-
thermore, alkylation of the viral RNA within the intact capsid
by dansyl sulfonate aziridine was strongly reduced by the drug
WIN 52084 [11–13]. Drugs restricting breathing also block
uncoating of some HRV serotypes [14,15], suggesting that do-
mains of the capsid proteins need to move for externalization
of the viral RNA [16]. The movements lead to enlargement of
the virion and generate openings or channels through which
the RNA is released [17–19].
The conformational modiﬁcations of the HRV capsid re-
quired for cell entry are catalyzed either by exposure to
low pH [20], as is encountered in late endosomes, in vitro
by incubation at temperatures P 50 C [21,22] and, in the
case of major group HRVs, by ICAM-1 binding [14]. This
receptor can either directly trigger uncoating or prime HRVs
for RNA exit at a pH of between 5.5 and 6.0 [23]. There-
fore, ICAM-1 blocks virus infection both by prevention of
virus binding to the cell and by disruption of the viral
capsid [24].
LDLR, very-LDLR (VLDLR), and LDLR-related protein
(LRP) possess 7, 8, and 31 Ca2+ containing repeats, about
40 amino acid residues in length, in their N-terminal ligand
binding domains [25]. In previous work, we observed that: (i)
a tandem pentamer of VLDLR repeat 3 fused to maltose bind-
ing protein (MBP-V33333) strongly protects HeLa cells
against virus infection [7], (ii) the aﬃnity of a receptor mole-
cule for HRV2 strongly increases with the number of concate-
nated repeats [26], and (iii) MBP-V33333 binds HRV2 with
12:1 stoichiometry indicating multi-modular attachment [27].
These ﬁndings led us to ask whether the receptor derivatives
protected the cells only via competition with the cellular recep-
tors or whether other mechanisms, such as demonstrated for
ICAM-1 and for antibodies are also involved. Whereas
ICAM-1 can destabilize the virion (see above), certain IgG
molecules, provided the geometry of the epitopes allows biva-
lent binding, can stabilize. Such antibodies are believed to
neutralize via crosslinking the viral subunits thus preventing
the escape of the RNA from the capsid [28–30]. We here pres-
ent evidence for a novel virus neutralization mechanism; theation of European Biochemical Societies.
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changes in the HRV2 capsid that are required for cell entry
and RNA release.2. Materials and methods
2.1. Virus, receptor, and reagents
Human rhinovirus serotype 2, originally obtained from the Ameri-
can Type Culture Collection (ATCC), was produced and puriﬁed from
infected HeLa cell pellets as described previously in [5]. Virus was radi-
olabeled as described in [31]. RiboGreen dissolved in DMSO was ob-
tained as part of a kit for the determination of the RNA concentration
from Molecular Probes. MBP-V33333 was prepared as described in
[26,32] and dialyzed against Tris-buﬀered saline containing 2 mM
CaCl2 (TBSC) for 24 h at 4 C. Virus and receptor concentrations were
determined by capillary electrophoresis (CE) from the area of the
respective peaks [33]. Chemicals were purchased from E. Merck
(Darmstadt, Germany). For CE, the background electrolyte (BGE)
was 100 mM boric acid adjusted to pH 8.3 with NaOH and containing
10 mM SDS [33]. Samples were dissolved in half-concentrated BGE
without SDS or adjusted to closely match this composition. All reagent
solutions were prepared in deionized water and were degassed by ultra-
sonication for 10 min and centrifugation for 10 min in a tabletop cen-
trifuge at 12000 · g to remove dust particles.
2.2. Instrumentation
CE was carried out on a homemade instrument consisting of an un-
coated fused silica capillary (28.5 cm total length, 20.0 cm length to the
detector, 50 lm inner diameter; Composite Metal Services Ltd., Ilkley,
UK) equipped with a laser-induced ﬂuorescence (LIF) detector (Argon
laser, Laser-Physics, Reliant 50S-489, 50 mW; 488 nm). The capillary
was positioned in still air at room temperature without thermostating.
The emitted light was passed through a cut-oﬀ ﬁlter of 500 nm and fo-
cused by a microscopic lens system. Fluorescence intensity was mea-
sured with a photomultiplier (Hamamatsu H 5785). Injection of the
sample was performed hydrodynamically by lifting the injection inlet
by 3 cm for 15 s. Separation was at 7.5 kV at ambient temperature.
The capillary was conditioned by washing with about 100 ll of BGE
prior to each analysis. Data were collected and analyzed using Data-
Apex software (Prague, Czech Republic).
Analysis of conformational modiﬁcations of HRV2 were performed
with a 3DHPCE system (Agilent, Waldbronn, Germany), equipped
with a DAD detector; for separation an uncoated fused silica capillary
was used (total length 68.0 cm, 59.5 cm to detector, 50 lm inner diam-
eter; Composite Metal Services). Detection wavelengths were 205 and
260 nm. Samples were injected by applying pressure of 450 mbar s. The
fused silica capillary was thermostated at 20 C and separation was
carried out at 25 kV. Data were collected and analyzed using the Chem
Station software.
2.3. Dye penetration assay
A constant amount of virus in 50 mM HEPES buﬀer (pH 7.5) was
mixed with diﬀerent amounts of receptor in TBSC. From this solution,
1.5 ll was added to 4.5 ll of 100 mM borate buﬀer, pH 8.3 (BGE with-
out SDS) resulting in ﬁnal concentrations of 75 nM (virus) and of
receptor as given in the ﬁgures. The ﬁnal concentration of Ca2+ was
kept below 0.17 mM. The mixture was incubated at room temperature
for 90 min to allow complex formation. For RiboGreen penetration, a
mixture of 5.5 ll borate buﬀer (50 mM, pH 8.3) and 0.5 ll RiboGreen
solution in DMSO was added to the preformed complexes resulting in
a total volume of 12 ll. The mixtures were incubated at 37 C to allow
the dye to enter the virion. At 30, 60, and 120 min aliquots were re-
moved, mixed with 2 ll borate buﬀer and 0.5 ll ﬂuorescein solution (ﬁ-
nal concentration 1 nM) used as internal standard, and analyzed by
CE.
2.4. Analysis of virus conformation and determination of uncoating by
sucrose density centrifugation
HRV uncoating decreases the amount of infectious virus particles
with sedimentation around 150S and results in the appearance of
empty particles sedimenting at 80S. For analysis of virus conformationand uncoating, radiolabeled virus was run through linear 5–20% su-
crose density gradients in PBS buﬀer. Virions were ﬁrst incubated with-
out or with MBP-V33333 in 10 mM HEPES buﬀer (pH 8.0), 150 mM
NaCl containing 5% FCS for 30 min at 37 C. Samples (10 ll) were di-
luted ﬁve times with ice-cold 25 mM HEPES buﬀer, 150 mM NaCl
(pH 7.0, 6.5, and 6.0) and further incubated at 37 C for 30 min. The
ﬁnal pH was by 0.1 units higher than this dilution buﬀer. Virus samples
were chilled for 5 min on ice, loaded onto 5 ml sucrose density gradi-
ents and centrifuged at 40000 rpm and 4 C for 1 h in a SW50.1 rotor.
About 20 fractions were collected from the bottom and scintillation
counted. Uncoating was determined from the decrease in the counts
(cpm) of the native virus fractions in the virus samples treated with
low pH buﬀer ((% cpm untreated  % cpm treated/% cpm un-
treated) · 100).
2.5. Analysis of conformational modiﬁcations of HRV2 by CE
To estimate the pH of the virus–receptor mixtures, 8 ml Na-citrate
buﬀer (50 mM) adjusted to diﬀerent pH were combined with 2 ml of
a solution with the same composition as obtained from mixing virus
and receptor in the ﬁnal experiments. The pH values of these mixtures
were measured and it was assumed that the same values are obtained
upon mixing 1000-fold smaller volumes (i.e., 8 ll of the Na-citrate buf-
fer with 2 ll of virus (controls) or the mixture of virus and receptor);
these pH values are given in Fig. 3B. For complex formation, virus
was ﬁrst mixed 1:1 with 50 mM borate buﬀer, pH 8.3, resulting in a
concentration of 0.45 lM; MBP-V33333 was diluted 1:4 in the same
buﬀer. Then, equal volumes were combined resulting in ﬁnal concen-
trations of 0.23 lM virus and 17.4 lM receptor; this corresponds to
a 76-fold molar excess of receptor over virus. After incubation for
one hour at room temperature, the sample was diluted 1:5 with Na-
citrate buﬀer to give the desired pH and further incubated at room
temperature for 60 min. After CE analysis, the peak areas correspond-
ing to the virus–receptor complex were determined. Since VP1 migrates
at the same position as the complex, the percentage of conversion to
subviral particles (and as a consequence of the presence of SDS in
the BGE to VP1, 2, 3, 4, and RNA) was measured as follows: the area
between 9 and 10.2 min seen after incubation of the sample at pH 7.4
was taken as 0% conversion and after incubation at pH 5 was taken as
100% conversion.3. Results
RiboGreen is a ﬂuorescent nucleic acid stain used in quanti-
tation of RNA [34]. We have previously shown that the geno-
mic RNA within intact HRV2 can be labeled with this dye [35],
indicating that the capsid is permeable for RiboGreen. A sim-
ilar eﬀect had been demonstrated for HRV14, whos RNA be-
comes derivatized within the intact capsid upon incubation
with N-acetyl-aziridine or dansyl sulfonate aziridine [13]. Entry
of these latter compounds was inhibited by pocket-binding
antivirals presumably by preventing breathing [11]. We thus
asked whether access of RiboGreen would be inhibited by
MBP-V33333 that attaches with high avidity to HRV2 around
the ﬁvefold axis and thereby might stiﬀen the virion by cross-
linking viral subunits [27].
3.1. Penetration of RiboGreen into the virion is inhibited by
MBP-V33333 in a concentration-dependent manner
Virus was preincubated with diﬀerent concentrations of
MBP-V33333, RiboGreen was added, and the incubation
was continued for 30 min. Samples were analyzed by CE and
virus rendered ﬂuorescent upon penetration of the dye was
determined with LIF detection. In the absence of receptor
(control incubation), HRV2 gave rise to a well-deﬁned ﬂuores-
cent peak (Fig. 1, trace a). Preincubation with increasing recep-
tor concentrations shifted this peak towards longer migration
times corresponding to virus/receptor complexes; it also be-
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Fig. 1. Staining of the viral RNA with RiboGreen is inhibited in the
virus/receptor complex. HRV2 at 75 nM preincubated for 90 min at
room temperature in the absence (trace a) or in the presence of MBP-
V33333 at diﬀerent concentrations (traces b–f) was incubated with the
dye for 60 min at 37 C and subjected to CE analysis with ﬂuorescence
detection. Note the diﬀerent mobility of virus and virus/receptor
complex and the decrease in ﬂuorescence of the complex with
increasing saturation of the virus with receptor. IS, internal standard,
1 nM ﬂuorescein. In some cases, spikes were seen between 3.25 and
4.0 min. These were presumably caused by aggregates since they never
occurred at the same positions.
0 20 40 60 80 100 120
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8 0 µM
re
l. 
pe
ak
 a
re
a
Time (min)
0.2 µM
   1 µM
    2 µM
         5 µM 
         8 µM
       13 µM
0
10
20
30
40
50
60
70
80
90
100
 30 min
 60 min
 120 min%
 in
hi
bi
tio
n
receptor concentration (µM)
0 2     4 6  8 10 12     14 
A
B
Fig. 2. RiboGreen penetration into the virion increases with time of
incubation and is inhibited by MBP-V33333 in a concentration-
dependent manner. (A) Virus (75 nM) without receptor (0 lM) or
preincubated with MBP-V33333 as in Fig. 1 at the concentrations
indicated was incubated with RiboGreen at 37 C for 30, 60 and
120 min. (B) Inhibition of dye penetration as a function of the receptor
concentrations (data from A). Samples were analyzed by CE as in
Fig. 1 and the peak areas were calculated as related to the internal
standard.
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highest receptor concentration (8 lM; trace f), no peak was
seen indicating that no dye had penetrated into the virus/recep-
tor complex; the visible peak corresponds to the internal stan-
dard. Since the equilibrium dissociation constant KD of the
binding reaction is in the picomolar range [26], the virus is sat-
urated with receptor at the highest concentration.
Virus was then incubated for 30, 60, and 120 min in the pres-
ence of increasing receptor concentrations prior to analysis by
CE. As seen in Fig. 2A, the increase in the peak area of the ﬂuo-
rescent virus (related to the internal standard) was strong within
the ﬁrst 30 min, but then leveled oﬀ. A clear negative correlation
between concentration of the receptor and uptake of the dye
was apparent; this is more clearly seen in Fig. 2B in which inhi-
bition of dye penetration as a function of the receptor concen-
tration is depicted. Entry of the dye was inhibited by about
80% at the highest receptor concentration investigated. Resid-
ual ﬂuorescence might originate from damaged virions.
3.2. MBP-V33333 inhibits structural changes of the virion
HRVs undergo conformational changes at low pH in vitro
and in vivo in the acidic endosomal lumen [21]. We thus inves-
tigated whether the receptor would protect HRV2 against
these modiﬁcations in a manner similar to that of antiviral
pocket-binding drugs [36]. HRV2 was preincubated without
(control) or with excess MBP-V33333 resulting in a saturated
complex [27], and adjusted to pH 7.4 and 5.9, respectively,
and analyzed by CE. As depicted in Fig. 3A, the virus peak
seen in the control (trace a) vanished upon incubation at pH
5.9 and peaks corresponding to VP1, VP2, VP3, and the
RNA appeared (trace b). Native virus is converted into subvi-
ral particles at low pH that are stable in the absence of SDS
[22]. However, since the BGE contains SDS these particles
are further disrupted into their components; note that VP4 is
not detectable under these conditions. In the sample of the
virus that had been pre-incubated with receptor only a broad
peak was seen despite incubation at pH 5.9. This indicates thatthe virus complexed with the receptor was stable (trace c; com-
pare to Fig. 1).
Complexes formed with excess receptor were then adjusted
to the pH values indicated in Fig. 3B and analyzed by CE.
Comparison with the pH-dependent disintegration of the virus
in the absence of the receptor clearly indicates that the pH
threshold of uncoating was shifted towards lower pH values;
without receptor no intact virus remained upon incubation
at pH 5.9 (i.e., 100% were converted). Conversely, from the
virus complex formed with the receptor about 50% were still
present after incubation at pH 5.9. At pH 5.6, the virus was
disintegrated regardless of the presence of the receptor.
3.3. MBP-V33333 inhibits structural changes of the virion at low
pH
To examine the stabilizing eﬀect of the receptor by other
means, we analyzed the capsid integrity by sucrose gradient
sedimentation [21,23]. Low-pH mediated uncoating of virus
and of virus–receptor complexes was monitored as decrease
in the amount of [35S]methionine labeled intact virus particles.
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Fig. 3. HRV2 is stabilized by MBP-V33333 against denaturation at
low pH. (A) CE analysis of virus (230 nM) incubated at pH 7.0 (trace
a), at pH 5.9 without preincubation (trace b) and with preincubation
(trace c) in the presence of 17.4 lM MBP-V33333. The peaks between
6 and 7 min correspond to buﬀer substances. (B) Virus not preincu-
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incubated at the pH values indicated and analyzed as in (A). Percent
conversion was calculated as detailed in Section 2. (C) Radiolabeled
virus (rec.) and virus/receptor complexes obtained with the respective
MBP-V33333 concentrations (+rec.) were prepared by incubation at
37 C for 30 min and diluted 5 times with ice-cold buﬀers of the
indicated pH. After further incubation at 37 C for 30 min, the samples
were analyzed by 5–20% sucrose density gradient centrifugation and
conversion into subviral particles was determined from the radioac-
tivity in the fractions corresponding to native virus. The mean of 2 (pH
6.5) and 3 (pH 6.0 and pH 7.0) experiments ±SD is presented.
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about 80S on sucrose density gradients [22]. In accordance
with the results above and [36] almost complete uncoating
was observed after 30 min incubation at pH 6.0 and physiolog-
ical temperature (Fig. 3C). However, virus uncoating was
clearly decreased with increasing concentration of MBP-
V33333 used for the virus–receptor complex formation. Highconcentration of receptor (i.e., conditions of virus saturated
with receptor) blocked HRV2 uncoating at pH 6.0 almost
completely, demonstrating that the virus was stabilized by
the receptor. Conversely, in the absence of receptor there
was some marginal conversion even at pH 7. This was entirely
prevented by receptor concentrations exceeding 0.5 lM.4. Discussion
The release of genomic viral RNA from HRVs requires the
viral capsid to enlarge and open a channel or conduit, most
probably at least at one of the 12 vertices [17–19]. These struc-
tural changes appear to depend on the presence of cavities in
the virion; it is believed that segments of the polypeptides move
into these hollows upon the transition of the virus from the na-
tive to the subviral conformation. Clearly, the natural pocket
factor must be expelled before this can occur [37].
Since we recently noticed a strong increase of virus-neutral-
izing activity of MBP-V3 upon concatenation with a maximum
activity seen for MBP-V33333, we wondered whether this ef-
fect was due to the receptor forming a ring-like structure or
hoop around the vertices of the virion that might prevent
movements of the subunits. Using penetration of RiboGreen,
a ﬂuorescent nucleic acid dye, into the virion as a measure of
ﬂexibility of the viral capsid we indeed found that this artiﬁcial
receptor strongly inhibited penetration of RiboGreen into the
capsid in a concentration-dependent manner. We also found
that the receptor protected the virus against low-pH induced
structural changes as occur during uncoating. Taken together,
this artiﬁcial receptor composed of ﬁve identical modules sta-
bilizes the virus indicating that its neutralizing activity is not
only due to competition for cellular receptors but also to pre-
vention of uncoating.
The pH of approximate half maximum transition of native
to subviral particles (pH 6) is somewhat higher as observed
in an assay where the pH-dependent appearance of C-antigen
was monitored by using the conformation-speciﬁc monoclonal
antibody 2G2 in an in vitro (pH 5.7 [36]) or an in vivo assay
(pH 5.5 [38]). This might be due to the diﬀerent conditions
used for analysis. As it was not our intention to determine
the exact pH of the structural transition of the virus but rather
to study whether the receptor aﬀects this process, we believe
that the values agree rather well.
Increase of the aﬃnity between HRV14 and its receptor,
ICAM-1, by site-directed mutagenesis of viral amino acid resi-
dues involved in the interaction led to a small plaque phenotype
[39]. This suggests that the interaction between virus and recep-
tor needs to be ﬁne-tuned in order to allow for eﬃcient binding
but at the same time to permit dissociation inside the cell at the
appropriate location [38].Our experiments were carried outwith
an artiﬁcial receptor and it is unlikely that theymimic the natural
situation. Nevertheless, the results indicate that multimodule
attachment, as can be assumed for the natural membrane recep-
tors LDLR, VLDLR, and LRP might have stabilizing eﬀects.
Further experiments will show whether this is indeed the case
and if so, how this aﬀects the eﬃciency of infection.
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